Coronary Heart Disease (CHD) Clinical Trial
— psychocardioOfficial title:
The Contribution of Personality Traits to Marital Satisfaction, Well Being and Physical Health in Couples Coping With Coronary Heart Disease Versus a Control Group
The main purpose of this study is to examine the contribution of personality traits to marital satisfaction and well -being among couples coping with Coronary Heart Disease (CHD) and couples from the general population, and to health promoting behaviors and physical recovery among the ill partners.
Status | Recruiting |
Enrollment | 130 |
Est. completion date | December 2014 |
Est. primary completion date | December 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Jewish men with a Clinical diagnosis of first Acute Coronary Syndrome (ACS: myocardial infarction (MI) or unstable angina (UA)) - Partners also agree to participate in the study Exclusion Criteria: - a history of a previous cardiac event - a diagnosis other than ACS - co-morbid conditions (such as a severe psychiatric illness, end state renal disease or severe cancer) - absence of a spouse - inability to be interviewed in Hebrew |
Observational Model: Case Control, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Israel | Department of Cardiology, Meir Medical Center | Kefar Saba |
Lead Sponsor | Collaborator |
---|---|
Meir Medical Center |
Israel,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Patients' medication adherence | Medication adherence: the number of prescriptions filled as a function of the frequency of the medication. will be obtained from the central database of the patients' HMO. | Six months after hospitalization | No |
Primary | Change in blood level Cholesterol | Change in blood level Cholesterol:Patients' blood level Cholesterol will be taken at baseline from their medical files and at the follow-up patients will be invited again for blood tests. | six mounths | No |
Primary | Change in body mass index | Change in body mass index:Patients' BMI will be measured at baseline and Patients will be asked to weigh in again at the six-month follow-up | six-month | No |
Primary | Smoking cessation | Smoking cessation:self-report measures of the patients'smoking cessation at follow-up. | six months | No |
Primary | Change in blood level Cholesterol | Change in blood level Cholesterol:Patients' blood level Cholesterol will be taken at baseline and at the follow-up from their medical files. | six mounths | No |
Secondary | Patients' and spouses' depression and anxiety symptoms | Depression and anxiety- depressive and anxiety symptoms will be measured using the Brief Symptom Inventory [BSI;( Derogatis & Melisaratos, 1983)]. Each participant will be asked to rate the degree to which he has suffered from each symptom during the previous month on a scale ranging from 0 (not at all) to 4 (very much). | Case group- the instruments will be administered twice: at baseline and at the six- month follow-up Control group- the instruments will be administered at a one point of time | No |
Secondary | Patients' and spouses' marital satisfaction | Marital satisfaction - marital satisfaction will be measured using the EMS-ENRICH Marital Satisfaction Scale (Lavee, 1995(. | Case group- the instruments will be administered twice: at baseline and at the six- month follow-up Control group- the instruments will be administered at a one point of time | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT01631409 -
Estimation of the Long Term Effectiveness of Routine Use of Cardiac Shock Wave Therapy
|
N/A | |
Completed |
NCT04610892 -
Efficacy and Safety of MEDI6570 in Patients With a History of Myocardial Infarction
|
Phase 2 | |
Recruiting |
NCT05834673 -
VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN)
|
Phase 4 | |
Completed |
NCT00685776 -
Study to Assess the Tolerability and Efficacy of Anacetrapib in Patients With Coronary Heart Disease (CHD) or CHD Risk-Equivalent Disease (MK-0859-019)
|
Phase 3 | |
Active, not recruiting |
NCT03872401 -
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
|
Phase 3 | |
Completed |
NCT03427489 -
A Biorepository for Coronary Heart Disease in Qatar
|
||
Active, not recruiting |
NCT01864031 -
The Role of Alcohol Consumption in the Aetiology of Different Cardiovascular Disease Phenotypes: a CALIBER Study
|
N/A | |
Not yet recruiting |
NCT05178602 -
The Effect of TaiChi on Ischemic Burden of Patients With Coronary Heart Disease Complicated With Renal Insufficiency
|
N/A | |
Not yet recruiting |
NCT06216847 -
Clinical Outcomes of Patients With Coronary Artery Disease
|
||
Recruiting |
NCT06170541 -
CORE-COMPARE Pilot Study
|
N/A |